MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
INO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Inovio Pharmaceuticals (INO) Ownership - Who owns Inovio Pharmaceuticals?

Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Medical Specialties
Address
660 West Germantown Pike
Phone
+1 267 440-4200
Employees
112
Web
https://www.inovio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
90.5M
P/E Ratio
N/A
Total Cash
37.68M
Projected Growth
N/A
Total Debt
8.7M
Revenue
N/A
Risk (Beta)
1.21
Dividend Yield
N/A
Total Cash/Share
0.46
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
INO
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for INO
A.I. Advisor
published General Information

General Information

a developer of synthetic vaccines and immune therapies for cancers and infectious diseases

Industry Biotechnology

Profile
Details
Industry
Medical Specialties
Address
660 West Germantown Pike
Phone
+1 267 440-4200
Employees
112
Web
https://www.inovio.com